Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
46.5M
-
Shares change
-
+2.86M
-
Total reported value, excl. options
-
$948M
-
Value change
-
+$64.7M
-
Put/Call ratio
-
0.74
-
Number of buys
-
116
-
Number of sells
-
-92
-
Price
-
$20.37
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2016
243 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2016.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.5M shares
of 56M outstanding shares and own 82.99% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (3.1M shares), Ranger Investment Management, L.P. (2.32M shares), VANGUARD GROUP INC (1.96M shares), GLENMEDE TRUST CO NA (1.78M shares), Bank of New York Mellon Corp (1.66M shares), Invesco Ltd. (1.58M shares), ACADIAN ASSET MANAGEMENT LLC (1.53M shares), Fiera Capital Corp (1.35M shares), Neumeier Poma Investment Counsel LLC (1.21M shares), and STATE STREET CORP (1.15M shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.